Log in to save to my catalogue

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients wit...

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients wit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextcollege_GICCO_A61855605

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

About this item

Full title

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

Publisher

United States: American Diabetes Association

Journal title

Diabetes (New York, N.Y.), 2000-04, Vol.49 (4), p.633-639

Language

English

Formats

Publication information

Publisher

United States: American Diabetes Association

More information

Scope and Contents

Contents

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and
in lean and obese normal subjects.
Y T Kruszynska ,
J G Yu ,
J M Olefsky and
B E Sobel
Department of Endocrinology and Metabolism, University of California San Diego, Veterans Administration Center, La Jolla 92...

Alternative Titles

Full title

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_incontextcollege_GICCO_A61855605

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextcollege_GICCO_A61855605

Other Identifiers

ISSN

0012-1797

E-ISSN

1939-327X

DOI

10.2337/diabetes.49.4.633

How to access this item